AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CISATRACURIUM BESYLATE
8 registrations across 4 African markets— 7 active
Markets with CISATRACURIUM BESYLATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CISATRACURIUM BESYLATE 2mg /ml | 🇬🇭Ghana | — | active | Sept 2028 |
| CISATRACURIUM BESYLATE 2mg /ml | 🇬🇭Ghana | — | active | Sept 2028 |
| NIMBEX SOLUTION; INJECTION | 🇿🇼Zimbabwe | PHARMACARE LTD | active | Dec 2027 |
| NIMBEX SOLUTION; INJECTION | 🇿🇼Zimbabwe | PHARMACARE LTD | active | Dec 2027 |
| NIMBEX SOLUTION; INJECTION | 🇿🇼Zimbabwe | PHARMACARE LTD | active | Dec 2027 |
| CISATRA 10ML INJECTION Injection | 🇰🇪Kenya | THEMIS MEDICARE LIMITED | active | Nov 2027 |
| CISATRA 5ML INJECTION Injection | 🇰🇪Kenya | THEMIS MEDICARE LTD | active | Sept 2026 |
| NIMBEX 2MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
CISATRACURIUM BESYLATE in Africa — Regulatory Overview
CISATRACURIUM BESYLATE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Ghana, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.